Patrick William Chambers

Dr. Patrick William Chambers

TMMC, Torrance, California, USA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024
Verified
Preprint
Open access
PDF file
PCPatrick William Chambers
Patrick William Chambers
Magnesium (Mg) is not prominent among the list of well-known anti-aging agents. Yet, the signs and symptoms of aging mimic those of Mg deficiency. Mg is required for nearly a thousand enzymatic reactions. This narrative review does not correlate Mg status with clinical data on agents linked to longevity. The approach is more novel and highlights specific Mg-dependent physiologic reactions required by these longevity-linked biomarkers. Many of these share common pathways to extend healthspan. Mg is a required cofactor in the synthesis of vitamin D and melatonin and in the activation of six of the eight B vitamins. It is a required cofactor for all CYP450 enzymes. It is directly responsible for the appropriate methylation of proteins and DNA, which control the epigenome. The MTHFR (methylenetetrahydrofolate reductase) 677T allele that compromises methylation is present in a majority of Americans. Aberrant methylation predicts the severity of Covid-19 and its persistence into long Covid. Mg is a silent benefactor that may indirectly link these longevity agents, but only if viewed in context with calcium (Ca), i.e., Ca:Mg. Both compete for the same receptor. To fully exploit these longevity agents, sufficient Mg is required. The pertinent physiology is presented, although cause and effect await publication of supporting clinical data.

31 December 2007 in Medical Hypotheses
Verified
Journal Article
Closed access
PCPatrick William Chambers
Patrick William Chambers


9 April 2024
Verified
Preprint
Open access
PDF file
PCPatrick William Chambers
Patrick William Chambers
“All diseases originate in the gut.” Hippocrates (400 BC) A healthy gut microbiome via the gut-brain-axis elevates heart rate variability (HRV), a general measure of health and well-being. A dysbiotic gut microbiome, low in biodiversity and butyrate producers, can alter tryptophan metabolism (ATM) and increase the kynurenine to tryptophan ratio (KTR) with release of proinflammatory cytokines, predominantly TNF-α, IL-6, and IL-1β. These also characterize chronic inflammation, oxidative stress, and a multitude of diseases. Also proposed is the gut-lung dysbiosis concept and consequent degradation of ACE2 (richest in lungs and gut). Leaky gut (and lung) induced autoantibodies (AAs) related to G-protein coupled receptors (GPCRs) in combination with increased Ang II further potentiate oxidative stress. The underappreciated pathogenic role of these receptors on invading Candida hyphae is explored. The efficacy of fecal microbiome transplantation (FMT) in treating dementia, cancer, and autoimmunity supports the plausibility of success with “FMT-lite”. This triple play of prebiotic (d-mannose), probiotic (bifidobacteria and lactobacilli), and postbiotic (butyrate) might improve intestinal barrier integrity, oppose entry of GPCR antigens (epitopes), suppress the inflammatory cytokine triad, balance IFN-γ and TGF-β, suppress oxidative stress, depress KTR, elevate HRV, and extend lifespan and its quality.

24 June 2024
Verified
Preprint
Open access
PDF file
PCPatrick William Chambers
Patrick William Chambers
The pandemic has supercharged growing awareness of the gut microbiome as a critical determinant of human health. “Long haulers” share microbiomes similar to those seen in myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia, all frequently associated with Candida overgrowth (CO). Candida can synthesize its own IDO, altering tryptophan metabolism (ATM). Zonulin, a circulating protein that increases intestinal and endothelial permeability, has emerged as a central player. Candida hyphal walls express proteins analogous to gliadin/gluten, e.g., celiac disease (CeD), and mannans, e.g., Crohn’s disease (CrD), that may trigger antigliadin and anti-Gq coupled GPCR auto-antibodies linked to their lectin binding domain respectively. Hyphal mannan may induce auto-antibodies to AT1Rs, α1-ARs, mAChRs, and β2-ARs, prominent in LC, and regulate T cell receptors (TCRs) and regulatory B cell function, compromised in not only LC (vitiligo, psoriasis, alopecia) but also SLE, RA, and many other autoimmune diseases. All are Gq coupled GPCRs. The spike protein S on SARS CoV2 can attach to both the ACE2 receptor (required for tryptophan absorption) and Toll-like receptor4 (TLR4) bearing endothelial cells and enterocytes. Spike protein S is persistent in most with LC and, as a ligand for TLR4, can also activate zonulin. S can also activate the NLRP3 inflammasome, as can candidalysin. This inflammasome is directly connected to dementia, cancer, autoimmunity, and obesity. Candidalysin causes hypercitrullination, instrumental in creating ACPAs (anti-citrullinated peptide antibodies) linked to LC, MCAS (mast cell activation syndrome), HSD (hypermobility spectrum disorder), and APS (antiphospholipid syndrome). A hypothetical pathophysiologic model is proposed implicating pre-existing CO, aggravated by Covid-19, in not only the genesis of LC but also that of autoimmune disease, dementia, cancer, many chronic diseases, and aging.

12 December 2024 in Microbes & Immunity
Verified
Journal Article
Open access
PDF file
PCPatrick William Chambers
Patrick William Chambers
Candida is traditionally considered an opportunistic pathogen. However, recent research, accelerated by COVID-19, has raised thought-provoking questions about the limitations of this view. Dietary carbohydrates and ethanol have been shown to enable its pathogenic transition. Its hyphae express epitopes that may initiate celiac and Crohn’s diseases. Hyphal mannan is potentially linked to Gq-coupled G-protein coupled receptors. Antibodies to these receptors include chemotactic cytokine receptors, which may mediate the escape of latent Epstein–Barr virus. Candida hyphae induce mast cells to release histamine and tryptase, which are associated with paroxysmal orthostatic tachycardia syndrome, mast cell activation syndrome, and hypermobility spectrum disorder—conditions frequently observed in long COVID (LC). Hyphae are also implicated in periodontitis, a condition linked to and potentially serving as a sentinel risk indicator for cancer, dementia, autoimmune disease, atherosclerotic cardiovascular disease, and chronic diseases in general. Candida yeast and hyphae can produce their own indoleamine dioxygenase (IDO), which antagonizes host IDO, impacting tryptophan metabolism. Altered tryptophan metabolism is observed in cancer, dementia, autoimmune diseases, and LC. Candida overgrowth (CO) also releases candidalysin, a toxin that suppresses competing intestinal bacteria, triggers inflammasomes, and causes hypercitrullination, a process associated with several autoimmune diseases and cancers. In addition, CO produces aspartyl protease, leading to the release of zonulin from intestinal epithelial cells, which increase intestinal and endothelial permeability – hallmarks of autoimmune diseases. Candida-induced acetaldehyde amplifies the harmful effects of a genetic variant, highly prevalent in Americans, linked to cancer, dementia, and autoimmune diseases. The gut microbiome is increasingly recognized as critical to overall health, and hyphae may play a major role in determining its composition. In this review, the roles of cholecalciferol, tryptophan, and magnesium in counteracting the yeast-to-hyphae transition and invasion are explored. The approach presented here is conceptual rather than empirical.